Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Renal Anemia Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to ...

Investigators found sex and racial differences in the risk for end-stage kidney disease among patients with CKD anemia. Anemia may lead to chronic kidney disease (CKD) progression and kidney failure, ...

Among patients with diabetic kidney disease (DKD), those with anemia may especially reap cardiovascular benefits from finerenone treatment. Finerenone treatment reduces cardiovascular and kidney risks ...

daily multivitamin does not reduce the risks of cvd in men Iron therapy and erythropoiesis-stimulating agents are not always effective for anemia in patients with CKD. Nutritional interventions may be ...

Akebia Therapeutics (NASDAQ:AKBA) shares surged over 25% premarket on Thursday after the U.S. Food and Drug Administration (FDA) approved its Vafseo (vadadustat) tablets for the treatment of anemia ...

Please provide your email address to receive an email when new articles are posted on . During the last 3 decades, only one class of drugs – erythropoiesis-stimulating agents – has been available to ...

The US Food and Drug Administration (FDA) has approved daprodustat (Jesduvroq), the first oral treatment for anemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at ...

Members of Congress introduce a bill to force Medicare to cover a drug they say will protect CKD patients during the COVID-19 pandemic. CMS’ decision to exclude a treatment for renal anemia from ...

Anemia caused by chronic kidney disease can be treated with injectable drugs but various pharmaceutical industry players have been pursuing alternatives that offer patients the convenience of a pill.

In an analysis of outpatient data from over 5 million adults, hemoglobin level was < 10 g/dl in over 20% with advanced kidney disease but less than 4% were treated with erythpoiesis-stimulating agents ...

The presence and severity of anemia in kidney disease increasesmarkedly with lower estimated glomerular filtration rates (eGFRs) and is associated with multiple adverse outcomes, a large cohort study ...

Medically reviewed by Oliver Eng, MDKey TakeawaysBlood cancers like leukemia hinder the production of red blood cells, ...